SCIENTIFIC AND MEDICAL ACCOUNTABILITY STANDARDS WORKING GROUP
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

OPEN SESSION

1. Welcome from Co-chairs
2. Call to Order & Roll Call
3. Staff Report
     a. Regulatory update / revisions to MES regulations
     b. Overview briefing on CIRM Compliance Program
     c. Scientific update on types of new cell line awards/derivations funded by CIRM
4. Regulatory and Policy Considerations:
     a. Briefing Memo: Use of Cell Lines Derived Prior to Effective-Date of CIRM MES Regulations
     b. Briefing Memo: Use of Embryos Created for Reproductive Purposes with Paid Gametes
          i. Policy Context: CIRM, California, National and international guidelines and regulations governing
             donation embryos
          ii. Legal Context: Review of Proposition 71’s language governing donation and use of cells
         iii. Social and Scientific Context: Panel of presenters discussing social and scientific consideration relating
              to embryo donation and cell line derivation.
                   1. 7/18 comments
5. California Department of Public Health’s Reporting Requirements for Oocyte Donation for Research
6. Additional Policy Considerations
7. Adjournment

Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.